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372 The Journal of Thoracic and CardioBackground: Regional myocardial acidosis, as measured with tissue pH elec-
trodes during cardiac surgery, has been shown to be reflective of regional
myocardial ischemia. This study examined the relationship between intraoper-
ative regional myocardial acidosis and long-term survival of patients undergoing
cardiac surgery with cardiopulmonary bypass.
Methods: A total of 496 adult patients who underwent valve replacement,
coronary artery revascularization, or both with intraoperative myocardial pH
monitoring in the anterior and posterior left ventricular walls were followed up
for 3 to 17 years (average 10.2  4.9 years) for all cause mortality. Regional
myocardial acidosis in each patient was defined by the lower of the anterior and
posterior wall pH values.
Results: A bivariate automatic interaction detection analysis identified three signif-
icant regional myocardial acidosis thresholds that affected long-term mortality:
pH37C less than 6.63 before aortic crossclamping, integrated mean pH37C less than
6.34 during the period of aortic crossclamping, and pH37C less than 6.73 at
discontinuation of cardiopulmonary bypass. Cox proportional hazard regression
analysis identified each of these thresholds to be independently determinant of
survival, with pH37C during aortic crossclamping having the highest risk ratio (risk
ratio 2.15, 95% confidence interval 1.37-3.37). Raising pH37C from lower than
threshold before aortic crossclamping to higher than threshold during clamping
increased the median survival by 40.2%.
Conclusion: In adult patients undergoing cardiac surgery with cardiopulmonary bypass,
regional myocardial ischemic acidosis before aortic crossclamping, during aortic cross-
clamping, and at discontinuation of cardiopulmonary bypass are independently associ-
ated with reduced long-term postoperative survival. Reversing or avoiding myocardial
acidosis during cardiac surgery improves long-term patient survival.
The quest for an intraoperative on-line metabolic marker of regionalmyocardial tissue ischemia has been the subject of basic and clinicaltranslational research in our laboratory since 1972.1 During the firstphase of this research (1972-1979), a rise in myocardial tissue PCO2,measured with mass spectrometry, and a fall in myocardial tissuepH, measured with a newly developed electrode, were validated in a
series of large animal experiments as quantitative measures of the extent of regional
vascular Surgery ● February 2005
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Pmyocardial ischemia and decreased coronary perfusion. The
pH-sensing methodology was further developed during the
subsequent phases of this research and was brought to the
operating room in 1982, enabling for the first time the
continuous monitoring of regional myocardial pH through-
out the entire intraoperative course of a cardiac surgical
operation.2 Early in the intraoperative monitoring experi-
ence, wide variations in myocardial pH between the anterior
and posterior left ventricular walls were observed, under-
scoring a need for routine monitoring of myocardial pH in
both walls simultaneously. The first 8 years of clinical
myocardial pH monitoring at our center were mostly obser-
vational, aiming primarily to characterize the time course
and clinical correlates of regional myocardial pH changes
and validating in patients the role of myocardial tissue
acidosis as a quantitative measure of regional myocardial
ischemia and lack of regional delivery of the cardioplegic
solution.2-11 Considering that normal myocardial pH is 7.2,
regional myocardial acidosis was observed in varying de-
grees and with varied frequencies throughout the course of
cardiopulmonary bypass (CPB).1 Before the period of aortic
crossclamping (AC), when the pH electrodes were first
placed in the heart, regional myocardial acidosis was ob-
served mostly in patients with severe coronary artery dis-
ease or left ventricular hypertrophy, particularly in those
with unstable angina and a hibernating myocardium. During
the period of AC, progressive regional ischemia was invari-
ably observed in myocardial segments that were not reached
by the cardioplegic solution. Myocardial acidosis in these
segments reflected the lack of washout of locally accumu-
lated hydrogen ions.1,12 The regional distribution of the
cardioplegic solution during this period, as assessed by the
degree of washout of the hydrogen ion, was highly unpre-
dictable from one patient to another, despite the application
of standardized cardioplegia delivery protocols.1 Patients
who exhibited regional acidosis before AC were also more
likely to have regional acidosis develop during AC. Acido-
sis during AC correlated with clinical evidence of inade-
quate myocardial protection.2,7,11 After release of the AC,
during the period of reflow, persistent acidosis was more
likely to be observed in patients who had sustained severe
regional acidosis during AC and in patients who had inad-
equate coronary revascularization. Inadequate revascular-
ization was assessed by the failure of myocardial pH to rise
after establishing flow through newly constructed grafts.13
Hearts that did not have acidosis during AC and did not
show evidence of inadequate revascularization were most
likely to defibrillate spontaneously after AC and to be
weaned from CPB without inotropic support, irrespective of
the duration of AC.1
After the initial observational phase of intraoperative
myocardial pH monitoring, pH-guided myocardial manage-
ment techniques were gradually developed at our institu-
The Journal of Thoracition, mostly aimed at reducing intraoperative regional myo-
cardial acidosis and ensuring effective and homogeneous
delivery of the cardioplegic solution during AC.1 This study
was conducted to elucidate further the clinical significance
of intraoperative myocardial acidosis/ischemia and its re-
versal in the course of cardiac surgery by relating the
myocardial pH changes before AC, during AC, and at end
of reperfusion to the long-term survival of 496 patients who
were followed up for an average of 10 years after undergo-
ing cardiac surgery with intraoperative myocardial pH mon-
itoring.
Materials and Methods
Between 1982 and 1997, a total of 535 cardiac surgery patients
underwent intraoperative on-line monitoring of myocardial tissue
pH in the anterior and posterior walls of the left ventricle. Insti-
tutional review board approval was obtained and patient consent
forms were used before obtaining Food and Drug Administration
approval for this technology in 1987. Because of limited availabil-
ity of the electrodes, they were used selectively, mostly in high-
risk patients who were anticipated to undergo relatively prolonged
periods of AC and in patients who consented to enroll in specific
studies in which myocardial pH was a study end point.
Intraoperative Measurement of Myocardial pH
The details of the monitoring methodology have been previously
published elsewhere.3 After institution of CPB, two right-angled
glass electrodes (1 mm in diameter and 10 mm in depth) were
inserted perpendicularly, one into the anterior left ventricular wall
and one into the posterior, midway between the base and the apex.
The electrodes were placed in the same topographic area in each
patient, irrespective of the nature of the patient’s coronary artery
disease if present. Myocardial temperature was measured with a
thermistor, which was incorporated into the mid shaft of the pH
electrode after 1993. A record of myocardial pH and temperature,
sampled every 20 seconds, was generated for each electrode. Three
pH values, corrected to 37°C (pH37C), were abstracted from this
record (Figure 1): (1) pH37C just before AC, (2) the integrated
mean pH37C during AC, and (3) the last pH37C value recorded
before removal of the electrode, usually within minutes after the
discontinuation of CPB. For each time point in each patient, the
lower pH37C value recorded from either the anterior or the poste-
rior electrode defined the magnitude of regional myocardial aci-
dosis encountered in that patient.
Methods of Myocardial Protection
All patients underwent a single period of AC and left ventricular
venting, mostly through the right superior pulmonary vein. Saphe-
nous vein grafts were constructed before valve replacement and
were used as conduits for cardioplegia delivery. Saphenous vein
graft proximal anastomoses were performed during partial aortic
occlusion after release of the AC and defibrillation. Hypothermic
crystalloid cardioplegia was replaced with hypothermic blood car-
dioplegia in 1991. Myocardial temperature during AC averaged
around 15°C during the first half of the study period and around
23°C during the second half. In valve operations, cardioplegia was
administered through the aortic root and the orifice of the main
c and Cardiovascular Surgery ● Volume 129, Number 2 373
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through the coronary sinus as well. In coronary artery bypass
grafting (and saphenous vein grafting accompanying valve re-
placement), cardioplegia was administered through the aortic root
and through the proximal ends of newly constructed grafts. Before
development of our pH-guided myocardial management tech-
niques, cardioplegia was administered continuously as much as
possible and stopped only when the operative field needed to be
clear.7
The initial period of myocardial pH monitoring in the study
patients (1982-1990) was purely observational, and no attempts
were made to alter myocardial management techniques on the
basis of myocardial pH readings. Subsequently, as the clinical
significance of intraoperative myocardial acidosis became more
apparent, we started exploring and developing pH-guided myocar-
dial management methods and techniques that would direct the
cardioplegic solution to acidotic segments and prevent or reverse
regional acidosis. By the end of 1997, we could elucidate a series
of intraoperative interventions with which severe regional myo-
cardial acidosis could be prevented in most patients, and the
specific sites of cardioplegia delivery, the temperature of the
cardioplegic solution, and the rate of delivery of the cardioplegic
solution were all determined primarily by the myocardial pH
response and varied widely from patient to patient.1
Assessment of Long-term Survival
The patients were initially tracked through the electronic patient
records of the Veterans Affairs (VA) Boston Healthcare System
and 9 additional referring VA medical centers in New England, as
well as the research records of clinical studies in which many of
the patients had been enrolled. This left 55 patients unaccounted
for, 50 of whom were listed as dead by the VA Beneficiary
Identification and Record Locator System (BIRLS), which has
Figure 1. Intraoperative myocardial pH37C recorded fro
(dotted line) walls of left ventricle of 65-year-old man
cumulative myocardial pH37C data were obtained for
values during AC were 7.30 in anterior wall and 6.25 in
pH37C values in each patient defined degree of regiona
time point.been shown to be 95% accurate in depicting the vital status of US
374 The Journal of Thoracic and Cardiovascular Surgery ● Febrveterans.14 Five patients were assumed to be alive because their
names did not appear in the BIRLS file. Exact cause of death
during the follow-up period could be ascertained for 81% of the
patients. Fifty-two percent of these patients died of a known
cardiac cause, mostly congestive heart failure.
Data and Statistical Analyses
Research assistants prospectively collected a standard set of data
on each patient undergoing intraoperative myocardial pH monitor-
ing. Information on diabetes was obtained retrospectively. Analy-
ses were performed only on complete sets of data. Missing values
were not imputed. The characteristics of the patients who survived
were compared with those of the patients who died during the
follow-up period with the t test for continuous variables and
chi-square test for categoric variables. Continuous preoperative
and intraoperative variables were then subjected to a bivariate
automatic interaction detection analysis,15,16 wherein the depen-
dent variable, death versus survival during the follow-up period,
was dichotomous. The automatic interaction detection analysis
identified the optimal cut point of the preoperative or intraopera-
tive variable that had the greatest reduction in the error variance of
the dependent variable; that is, the threshold value that would most
significantly affect long-term mortality. Preoperative and intraop-
erative variables were then entered into a multivariate Cox pro-
portional hazards regression analysis with long-term survival time
as the dependent variable. Dichotomized pH variables identified by
automatic interaction detection analysis to be significant at P .10
were categorically entered into the Cox regression analysis to
determine whether their respective threshold values were indepen-
dent predictors of long-term survival after adjustment for other
confounding variables. Because of the interdependence of the three
pH37C variables analyzed for this study, they were each entered
separately into the Cox regression model to determine whether
lectrodes placed in anterior (solid line) and posterior
rgoing aortic valve replacement. Time points at which
tudy are illustrated on figure. Integrated mean pH37C
rior wall. In this study, lower of anterior and posterior
dosis; in this patient it was posterior wall pH for eachm e
unde
this s
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PAll statistical analyses were performed with SAS Institute
statistical software version 8.2 (SAS Institute, Inc, Cary, NC).
Continuous variables are expressed as mean  SD, and categoric
variables are expressed as percentages.
Results
Thirty-nine (7.3%) of 535 consecutive patients who underwent
cardiac surgery with myocardial pH monitoring between June
1982 and August 1997 died within 30 postoperative days. Four
hundred ninety-six patients survived beyond the first 30 post-
operative days and were followed up to August 31, 2000 (an
average follow up of 10.2  4.9 years). The average survival
after the cardiac operation was 7.6  4.6 years; the median
survival was 6.7 years. The characteristics of the patients who
survived versus those who died during the period of follow-up
are shown in Table 1. Differences were noted in duration of
AC, duration of CPB, and the three myocardial pH37C mea-
surements.
Table 2 shows the results of automatic interaction detec-
tion analysis applied to the continuous preoperative and
intraoperative variables listed in Table 1. This bivariate
analytic algorithm identifies the breakpoint at which a vari-
able’s effect on long-term mortality is most significant.
Long-term mortality was most significantly affected when
TABLE 1. Comparison between living and dead patients
Living (n  287
n
Mean  SD
or %
Age at operation (y) 287 62.2 10.0
Sex
Female 5 1.7%
Male 282 98.3%
Presence of diabetes mellitus
Yes 56 24.4%
No 174 75.6%
Preoperative left ventricular
ejection fraction (%)
230 46.3 14.7
Operation type
CABG 163 56.8%
CABG plus valve replacement
or repair
67 23.3%
Valve replacement or repair 57 19.9%
Duration of AC (min) 286 79.1 35.3
Duration of CPB (min) 284 148.3 47.1
Year of operation within 1982-1990 95 33.1%
Year of operation within 1991-1997 185 66.9%
Myocardial tissue pH37C*
Before AC 183 6.65 0.27
Mean during AC 244 6.55 0.30
At discontinuation of CPB 234 7.03 0.30
CABG, Coronary artery bypass grafting.
*Lower of anterior or posterior pH37C value.patient age was greater than 52 years, duration of AC was
The Journal of Thoracigreater than 135 minutes, and the duration of CPB exceeded
212 minutes. A threshold of preoperative left ventricular
ejection fraction of 21 % or less was identified, but with
borderline significance (P  .10), reflecting the limited
sample size of this variable. Ejection fraction was confirmed
to be a significant predictor of long-term survival when it
was entered into the multivariate model. The degrees of
myocardial acidosis most significantly affecting long-term
survival were pH37C less than 6.63 before AC, mean pH37C
less than 6.35 during AC, and pH37C less than 6.73 at
discontinuation of CPB.
Table 3 shows the results of multivariate Cox propor-
tional hazard analysis where the dependent variable was the
postoperative survival time in years. Three models are pre-
sented, because each pH37C variable was entered into a
separate model, and there was no violation of the propor-
tional hazards assumption in any of the models. Acidosis in
either the anterior or posterior left ventricular wall during
each of the time points investigated in this study was inde-
pendently predictive of decreased long-term postoperative
survival. The risk ratio was highest for the mean pH37C
during AC (relative risk 2.15, P  .001), indicating that a
mean pH37C less than 6.34 during this period in either the
Dead (n  240)
P valueange n
Mean  SD
or % Range
24-84 239 63.6 8.5 40-90 .085
.463
2 1.2%
237 98.2%
49 30.4% .203
112 69.6%
10-88 183 44.8 15.3 10-82 .299
.124
116 48.3%
72 30.0%
52 21.7%
20-231 236 88.2 44.7 20-306 .01
63-231 236 176.9 72.0 56-467 .001
159 67.1%
77 32.9%
90-7.44 171 6.59 0.29 5.90-7.50 .052
62-7.36 210 6.49 0.33 5.61-7.32 .034
70-7.82 203 6.97 0.37 5.30-7.53 .002)
R
5.
5.
5.anterior or the posterior left ventricular wall was indepen-
c and Cardiovascular Surgery ● Volume 129, Number 2 375
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during the follow-up period than was pH37C of at least 6.34.
In addition to the myocardial pH37C variables, the three
models presented in Table 3 were consistent in identifying
the following variables as independent predictors of post-
operative survival: patient age, presence of diabetes melli-
tus, preoperative left ventricular ejection fraction, and total
duration of CPB. The year of surgery, type of operation, and
identity of the surgeon were not determinant of long-term
survival. The duration of AC and whether a sanguineous or
a crystalloid cardioplegic solution was used during this
period also did not have a significant independent influence
on long-term survival. All three models used the same set of
11 risk factors.
Linear regression analysis showed that within each ven-
tricular segment pH37C values at each of the three time
points were correlated with each other, with r ranging
between 0.4 and 0.5 and P  .001.
Risk-adjusted proportional hazards survival curves were
constructed to illustrate the effect of the three myocardial
pH37C variables that were found to be independent predictors
of survival (Figure 2). For each of these variables, the patients
were divided into two groups according to the breakpoint pH
determined by the automatic interaction detection analysis
(Table 2), after adjustment for all the confounding variables
shown to be significant in Table 3. The survival curves be-
tween the two patient groups in each of the three pH37C
variables were significantly different. Median survival in the
group with a pH37C of at least 6.63 before AC was 15.2 years,
in contrast to 11 years in the group with a pH37C lower than
6.63. Significant regional acidosis before AC was thus inde-
pendently associated with a 27.6% reduction in median sur-
vival (P  .021). Median survival in the group with a mean
pH37C of at least 6.35 during AC was 14.4 years, in contrast to
9.5 years in the group with a pH37C less than 6.63. Significant
regional acidosis during AC was thus independently associated
with a 34.0% reduction in median survival (P .001). Median
TABLE 2. Optimum threshold points of continuous variables
during period of follow-up as dependent variable
Thre
po
Age (y) 5
Preoperative left ventricular ejection fraction (%) 2
Duration of AC (min) 13
Duration of CPB (min) 21
Myocardial tissue pH37C*
Before AC
Mean during AC
At discontinuation of CPB
*Lower of anterior or posterior pH37C value.survival in the group with a pH37C of at least 6.73 at discon-
376 The Journal of Thoracic and Cardiovascular Surgery ● Febrtinuation of CPB was 14.1 years, in contrast to 10.5 years in the
group with a pH37C less than 6.74. Significant regional acidosis
at the end of CPB was thus independently associated with a
25.5% reduction in median survival (P  .023).
Figure 3 shows similarly risk-adjusted survival curves
of three groups of patients separated according to the
relationship between myocardial pH37C before AC and
mean myocardial pH37C during AC. Patients in whom
both values were above their respective thresholds (n 
77) had the best survival (median survival 15.1 years),
whereas patients in whom both values were below their
respective thresholds (n  49) had the worst survival
(median survival 7.9 years). Patients in whom pH37C was
below the threshold before AC and above the threshold
during AC (n  63) had a median survival of 13.2 years.
Thus, patients who exhibited significant regional acidosis
before and during AC had a 47.7% reduction in median
survival relative to patients who exhibited higher than
threshold pH37C during both periods, and raising the pH
from lower than threshold before AC to higher than
threshold during AC increased the median survival of
patients by 40.2%.
Discussion
Myocardial tissue acidosis, as measured with the technol-
ogy used in this study and with mass spectrometry, has been
shown to be quantitative of regional myocardial isch-
emia.17-20 As such, this study demonstrates that regional
myocardial acidosis/ischemia, encountered intraoperatively
either (1) before the application of the AC, (2) during AC,
and (3) at discontinuation of CPB, is independently deter-
minant of decreased long-term patient survival after cardiac
surgery. The study identified specific threshold levels of
acidosis that relate to postoperative outcomes to facilitate
the surgeon’s intraoperative decision making when he or
she uses pH-guided myocardial management clinically.
These thresholds were as follows: pH37C less than 6.63
h automatic interaction detection algorithm, with mortality
P value
Odds
ratio
95% Confidence
interval
.010 2.03 1.19-3.47
.102 2.12 0.86-5.24
.001 3.14 1.70-5.18
.001 3.16 1.92-5.18
.008 1.77 1.16-2.70
.004 1.86 1.22-2.84
.001 2.51 1.50-4.18wit
shold
int
2
1
5
2
6.63
6.34
6.73before AC, mean pH37C less than 6.35 during AC, and
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PTABLE 3. Predictive models based on Cox proportional hazards regression analysis with long-term survival as dependent
variable
Variable Model 1 Model 2 Model 3
Age at time of surgery
Risk ratio (CI) 1.03 (1.00-1.06) 1.05 (1.02-1.08) 1.04 (1.02-1.07)
P value .06 .001 .002
Presence of diabetes mellitus
Risk ratio (CI) 1.85 (1.13-3.03) 1.93 (1.24-3.04) 1.95 (1.23-3.09)
P value .015 .004 .004
Preoperative ejection fraction
Risk ratio (CI) 0.97 (0.95-0.98) 0.97 (0.96-0.99) 0.97 (0.95-0.98)
P value .001 .001 .001
Year of surgery (1991-1997)
Risk ratio (reference group) 1 1 1
Year of surgery (1982-1990)
Risk ratio (CI) 1.62 (0.89-2.92) 1.70 (0.96-3.01) 1.32 (0.74-2.36)
P value .11 .07 .35
Surgery type all other
Risk ratio (reference group) 1 1 1
Surgery type coronary artery bypass grafting
Risk ratio (CI) 2.09 (0.98-4.47) 1.85 (0.94-3.64) 1.36 (0.65-2.83)
P value .06 .08 .42
Surgeon 1
Risk ratio (reference group) 1 1 1
Surgeon 2
Risk ratio (CI) 0.92 (0.49-1.72) 0.80 (0.46-1.38) 0.75 (0.43-1.33)
P value .8 .42 .32
Surgeon 3
Risk ratio (CI) 0.51 (0.21-1.23) 0.59 (0.28-1.26) 0.67 (0.32-1.40)
P value .14 .17 .291
Duration of AC
Risk ratio (CI) 1.01 (0.99-1.02) 1.00 (0.99-1.02) 1.00 (0.99-1.01)
P value .37 .5 .94
Cardioplegia type blood
Risk ratio (reference group) 1 1
Cardioplegia type crystalloid
Risk ratio (CI) 1.42 (0.69-2.93) 1.29 (0.65-2.56) 1.54 (0.79-3.02)
P value .35 .46 .21
Duration of CPB
Risk ratio (CI) 1.01 (1.00-1.02) 1.01 (1.005-1.014) 1.01 (1.005-1.01)
P value .001 .001 .001
pH37C 6.63* before AC
Risk ratio (CI) 1.79 (1.09-2.93)
P value .021
Mean pH37C 6.34* during AC
Risk ratio (CI) 2.15 (1.37-3.37)
P value .001
pH37C 6.73* at end of CPB*
Risk ratio (CI) 1.70 (1.08-2.69)
P value .023
CI, 95% Confidence interval.
*Lower of anterior or posterior pH37C, each time point entered separately into model.The Journal of Thoracic and Cardiovascular Surgery ● Volume 129, Number 2 377
otto
Cardiopulmonary Support and Physiology Khuri et al
CSPpH37C less than 6.73 at discontinuation of CPB. Considering
that normal myocardial pH37 is 7.2, these thresholds repre-
sent varying levels of myocardial acidosis. Found to be
significant by automatic interaction detection analysis,
which is a univariate analysis, these thresholds were entered
as dichotomous variables into the multivariate Cox regres-
sion analysis, which confirmed the independent predictive
relationship between each of these variables and long-term
survival. In addition to intraoperative myocardial acidosis/
ischemia, independent determinants of decreased survival
Figure 2. Survival probability curves (adjusted for ot
model: age, preoperative ejection fraction, diabetes, y
duration of AC, and duration of CPB) of patients in w
threshold determined by automatic interaction detectio
Risk ratio (RR) and 95% confidence interval (CI) of gr
shown on figure. Vertical line at 50% survival proba
Survivals of patients in whom lower of anterior or p
(bottom) 6.63. B, Survivals of patients in whom lower of
was above (top) or below (bottom) 6.34 . C, Survivals of
at discontinuation of CPB was above (top) or below (bafter cardiac surgery were increased patient age, the pres-
378 The Journal of Thoracic and Cardiovascular Surgery ● Febrence of diabetes mellitus, decreased preoperative left ven-
tricular ejection fraction, and prolonged duration of CPB.
Whereas the latter variables have previously been shown to
be determinants, either directly21,22 or indirectly,23 of long-
term survival after cardiac surgery, this study is the first to
establish such a determinant role for intraoperative regional
acidosis. This study, however, does not account for the
impact of other, unmeasured variables on the long-term
survival of patients undergoing cardiac surgery.
Myocardial acidosis before AC is indicative of myocar-
ariables in the Cox proportional hazards regression
f surgery, operation type, surgeon, cardioplegia type,
pH37C was above (top line) or below (bottom line)
alysis to affect most significantly long-term mortality.
ith lower pH37C versus group with higher pH37C are
defines median survival for each patient group. A,
ior wall pH37C before AC was above (top) or below
rior or posterior wall integrated mean pH37C during AC
ents in whom lower of anterior or posterior wall pH37C
m) 6.34.her v
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oster
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Punderlying coronary artery disease or to the conditions of
perfusion, such as low systemic perfusion pressure in the
presence of coronary artery obstruction or left ventricular
hypertrophy.24
Regional myocardial acidosis during AC has been shown
to relate to adverse short-term clinical outcomes.2,7,11 In our
models, regional myocardial acidosis during this period had
the highest risk ratio and was the most important myocardial
pH variable in affecting long-term survival; it was also more
important than the other 4 non-pH variables in the model.
Previous studies have claimed that acidosis is protective to
the myocardium during ischemia.25,26 However, the range
of acidosis shown to be protective in those studies (pH
6.8-7.0) was much less severe than the acidosis found to be
adverse to long-term survival in this study (pH37C 6.35).
Intraoperative myocardial protection techniques in cardiac
surgery have been directed toward the prevention of myo-
cardial ischemia during AC, but there have not been clinical
tools with which the efficacy of myocardial protection could
be assessed on-line during this period. Regional acidosis
during this period is in good part the result of inadequate
delivery of the cardioplegic solution, which distributes in
the myocardial wall in a heterogeneous and unpredictable
manner.1,12 We have demonstrated that the delivery of the
cardioplegic solution to a specific segment of the left ven-
Figure 3. Survival probability curves (adjusted for othe
age, preoperative ejection fraction, diabetes, year of su
of AC, and duration of CPB) for three groups of patients
pH37C before AC and at end of CPB above thresholds re
group (bottom tracing) had both values below such thr
or posterior pH37C before AC below threshold determine
threshold. Risk ratio (RR) and 95% confidence interval (
on figure. Vertical line at 50% survival probability defitricular wall can be improved, and myocardial acidosis in
The Journal of Thoracithat segment can be reduced or totally ameliorated by a
variety of intraoperative maneuvers guided by myocardial
pH monitoring.1,3,9 The findings of this study confirm the
importance of preventing acidosis during AC and under-
score the potential of intraoperative pH-guided myocardial
management in improving postoperative long-term patient
survival.
Regional myocardial acidosis at discontinuation of CPB
is a reflection of either inadequate intraoperative myocardial
protection or inadequate myocardial revascularization. Both
of these factors account for most adverse events after car-
diac surgery.27 Inadequate intraoperative myocardial pro-
tection during AC precipitates a “no reflow” injury during
reperfusion28 and prevents adequate washout of the hydro-
gen ion, resulting in persistent acidosis throughout the re-
flow period. Inadequate revascularization also limits the
washout of the hydrogen ion and results in persistent isch-
emia. Successful restoration of blood flow to an ischemic
segment that has not been subject to reperfusion injury
should effect a complete washout of excess hydrogen ion
and eliminate tissue acidosis before discontinuation of
CPB.13,17
The relationship between acidosis before and during AC
underscores the importance of reversing regional acidosis
during AC. As demonstrated in Figure 3, patients who had
riables in Cox proportional hazards regression model:
y, operation type, surgeon, cardioplegia type, duration
t group (top tracing) had lower of anterior or posterior
tively determined to affect long-term survival. Second
lds. Third group (middle tracing) had lower of anterior
affect long-term survival, and that at end of CPB above
f second and third groups versus first group are shown
median survival for each patient group.r va
rger
. Firs
spec
esho
d to
CI) otheir pH37C raised from below threshold before to above
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CSPthreshold during AC had nearly twice the survival of pa-
tients in whom myocardial protective techniques failed to
raise pH37C from below threshold before to above threshold
during AC. The curves in Figure 3 show the effect of
acidosis on survival, corrected for the other confounding
variables identified in the study, including the year rang of
the operation, which approached statistical significance as a
separate independent predictive factor in model 2 (Table 3).
Recent experiments performed in animals and human
beings have shed light on a possible etiology for the adverse
effect of intraoperative myocardial acidosis on long-term
patient survival. Cell culture studies have shown acidosis to
be a primary trigger for apoptosis.29 We recently demon-
strated a direct relationship between acidosis and apoptosis
in atrial muscle tissue obtained from patients undergoing
cardiac surgery and in ventricular muscle biopsy specimens
obtained from pigs undergoing CPB.30 Pending the results
of ongoing studies that are attempting to elucidate the
relationship between apoptosis and congestive heart failure,
it may soon be possible to hypothesize that intraoperative
myocardial acidosis, through its acceleratory effect on ap-
optosis, may contribute to postoperative congestive heart
failure, which is one of the major causes of late mortality
after cardiac surgery.
In summary, this is the first documentation of the adverse
impact of intraoperative myocardial acidosis, and thus myo-
cardial ischemia, on long-term patient survival. The main
limitations of this study, however, are its observational
nature, the fact that it has emanated from a single institution,
and that any validation of the findings will require several
years, hopefully through multicenter studies that need to be
conducted when this technology becomes available for rou-
tine clinical use.
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Loscalzo and Dr Mark Pfeffer, who reviewed the data and early
versions of this article and provided valuable suggestions and
advice. The administrative help of Mrs Lynne Santangelo is also
acknowledged with gratitude.
References
1. Khuri SF. pH-guided myocardial management: evolution and clinical
application. 1st ed. Ann Arbor (MI): Terumo Cardiovascular Systems
Corporation; 2003.
2. Khuri SF, Josa M, Marston W, Braunwald NS, Smith B, Tow D, et al.
First report of intramyocardial pH in man. II. Assessment of adequacy
of myocardial preservation. J Thorac Cardiovasc Surg. 1983;86:667-
78.
3. Khabbaz KR, Zankoul F, Warner KG. Intraoperative metabolic mon-
itoring of the heart: II. Online measurement of myocardial tissue pH
Ann Thorac Surg. 2001;72:S2227-34.
4. Khuri SF, Marston WA, Josa M, Braunwald NS, Cavanaugh AC, Hunt
H, et al. Observations on 100 patients with continuous intraoperative
monitoring of intramyocardial pH. The adverse effects of ventricular
fibrillation and reperfusion. J Thorac Cardiovasc Surg. 1985;89:170-
82.5. Khuri SF, Warner KG, Marston W, Josa M, Sharma GV, Tow D, et
al. Intraoperative assessment of the physiologic significance of
380 The Journal of Thoracic and Cardiovascular Surgery ● Febrcoronary stenosis in humans. J Thorac Cardiovasc Surg.
1986;92:79-87.
6. Warner KG, Khuri SF, Kloner RA, Josa M, Dalecki-Chipperfield KM,
Butler MD, et al. Structural and metabolic correlates of cell injury in
the hypertrophied myocardium during valve replacement. J Thorac
Cardiovasc Surg. 1987;93:741-54.
7. Khuri SF, Warner KG, Josa M, Butler M, Hayes A, Hanson R, et al.
The superiority of continuous cold blood cardioplegia in the metabolic
protection of the hypertrophied human heart. J Thorac Cardiovasc
Surg. 1988;95:442-54.
8. Khuri SF, Axford TC, Garcia JP, Khabbaz KR, Dearani JA, Khait
I, et al. Metabolic correlates of myocardial stunning and the effect
of cardiopulmonary bypass. J Cardiac Surg. 1993;8(Suppl):262-70.
9. Khuri SF. Invited discussion on Khabbaz et al. Intraoperative meta-
bolic monitoring of the heart: II. Online measurement of myocardial
tissue pH. Ann Thorac Surg. 2001;72:S2233-4.
10. Dearani JA, Axford TC, Patel MA, Healey NA, Lavin PT, Khuri SF.
The role of myocardial temperature in monitoring the adequacy of
myocardial protection during cardiac surgery. Ann Thorac Surg. 2001;
72:S2235-43.
11. Biswas KS, Hossain M, Healey N, Birjiniuk V, Crittenden MD,
Khuri SF. Intraoperative myocardial acidosis predicts adverse out-
comes following cardiac surgery. Circulation. 1999;100(18 Suppl):
I596.
12. Khuri SF, Healey NA, Zolkewitz M, Khait I, Birjiniuk V, Doursounian
M. Determinants of myocardial tissue acidosis during prolonged aortic
clamping. Circulation. 1996;94(Suppl):I372.
13. Wolfe JA. The coronary artery bypass conduit: II. Assessment of the
quality of the distal anastomosis. Ann Thorac Surg, 2001;72:S2253-9.
14. Page WF, Mahan CM, Kang HK. Vital status ascertainment through
the files of the Department of Veteran Affairs and the Social Security
Administration. Ann Epidemiol. 1996;6:102-9.
15. Morgan JA, Sonquist JA. Problems in the analysis of survey data and
a proposal. J Am Stat Assoc. 1963;58:415-34.
16. Sonquist JA, Morgan JA. The detection of interaction effects: a report
on a computer program for the selection of optimal combinations of
explanatory variables. Ann Arbor (MI): Institute for Social Research,
University of Michigan; 1964.
17. Khuri SF, Kloner RA, Karaffa SA, Marston W, Taylor AD, Lai NC, et
al. The significance of the late fall in myocardial pCO2 and its
relationship to myocardial pH after regional occlusion in the dog. Circ
Res. 1985;56:537-47.
18. Khuri SF, Flaherty JT, O’Riordan JB, Pitt B, Brawley RK, Donahoo
JS, et al. Changes in intramyocardial ST segment voltage and gas
tensions with regional myocardial ischemia in the dog. Circ Res.
1975;37:455-63.
19. Khuri SF, Kloner RA, Hillis LD, Tow DE, Barsamian EM, Maroko
PR, et al. Intramural pCO2: a reliable index of the severity of myo-
cardial ischemic injury. Am J Physiol. 1979;237:H253-9.
20. Axford TC, Dearani JA, Khait I, Park WM, Patel MA, Doursounian M,
et al. Electrode-derived myocardial pH measurements reflect intracel-
lular myocardial metabolism assessed by phosphorus 31-nuclear mag-
netic resonance spectroscopy during normothermic ischemia. J Thorac
Cardiovasc Surg. 1992;103:902-7.
21. Peterson ED, Cowper PA, Jollis JG, Bebchuk JD, DeLong ER,
Muhlbaier LH, et al. Outcomes of coronary artery bypass graft surgery
in 24,461 patients aged 80 years or older. Circulation. 1995;92(9
Suppl):II85-91.
22. Turina J, Milincic J, Seifert B, Turina M. Valve replacement in chronic
aortic regurgitation. True predictors of survival after extended follow-
up. Circulation. 1998;98(19 Suppl):II100-7.
23. Milano CA, Kesler K, Archibald N, Sexton DJ, Jones RH. Mediasti-
nitis after coronary artery bypass graft surgery. Circulation. 1995;92:
2245-51.
24. Khuri SF, Brawley RK, O’Riordan JB, Donahoo JS, Pitt B, Gott VL.
The effect of cardiopulmonary bypass perfusion pressure on myocar-
dial gas tensions in the presence of coronary stenosis. Ann Thorac
Surg. 1975;20:661-70.
uary 2005
Khuri et al Cardiopulmonary Support and Physiology25. Koop A, Piper HM. Protection of energy status of hypoxic cardiomy-
ocytes by mild acidosis. J Mol Cell Cardiol. 1992;24:55-65.
26. Naylor WG, Ferrari R, Poole-Wilson PA, Yepez CE. A protective
effect of a mild acidosis on hypoxic heart muscle. J Mol Cell Cardiol.
1973;11:1053-71.
27. O’Connor GT, Birkmeyer JD, Dacey LJ, Quinton HB, Marrin CA, Birk-
meyer NJ, et al. Results of a regional study of modes of death associated
with coronary artery bypass grafting. Northern New England Cardiovas-The Journal of Thoraci28. Reffelman T, Kloner RA. The ‘no-reflow’ phenomenon; basic science
and clinical correlates. Heart. 2002;87:162-8.
29. Webster KA, Discher DJ, Kaiser S, Hernandez O, Sato B, Bishopric
NH. Hypoxia-activated apoptosis of cardiac myocytes requires reoxy-
genation or a pH shift and is independent of p53. J Clin Invest.
1999;104:239-52.
30. Thatte HS, Rhee JH, Zagarins S, Treanor PR, Birjiniuk V, Crittenden
MD, et al. Acidosis-induced apoptosis in the human and porcine heart.CS
Pcular Disease Study Group. Ann Thorac Surg. 1998;66:1323-8. Ann Thorac Surg. 2004;7:1376-83.c and Cardiovascular Surgery ● Volume 129, Number 2 381
